Preclinical and clinical modulation of anticancer drugs:
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Boca Raton u.a.
CRC Press
1993
|
Schriftenreihe: | Pharmacology and toxicology
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | VII, 364 S. Ill., graph. Darst. |
ISBN: | 0849372917 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV008717954 | ||
003 | DE-604 | ||
005 | 19940113 | ||
007 | t | ||
008 | 940105s1993 ad|| |||| 00||| engod | ||
020 | |a 0849372917 |9 0-8493-7291-7 | ||
035 | |a (OCoLC)27430107 | ||
035 | |a (DE-599)BVBBV008717954 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-188 | ||
050 | 0 | |a RC271.A35 | |
082 | 0 | |a 616.99/4061 |2 20 | |
084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
100 | 1 | |a Tew, Kenneth D. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Preclinical and clinical modulation of anticancer drugs |c Kenneth D. Tew ; Peter J. Houghton ; Janet A. Houghton |
264 | 1 | |a Boca Raton u.a. |b CRC Press |c 1993 | |
300 | |a VII, 364 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Pharmacology and toxicology | |
650 | 4 | |a Anticancéreux | |
650 | 2 | |a Antinéoplasiques - Pharmacologie | |
650 | 2 | |a Antinéoplasiques - usage thérapeutique | |
650 | 4 | |a Cancer - Traitement adjuvant | |
650 | 4 | |a Cellules cancéreuses - Résistance aux médicaments | |
650 | 7 | |a Chemotherapie |2 gtt | |
650 | 7 | |a Geneesmiddelen |2 gtt | |
650 | 7 | |a Kanker |2 gtt | |
650 | 2 | |a Résistance aux médicaments | |
650 | 2 | |a Tumeurs - Traitement médicamenteux | |
650 | 4 | |a Antineoplastic Agents |x pharmacology | |
650 | 4 | |a Antineoplastic Agents |x therapeutic use | |
650 | 4 | |a Cancer |x Adjuvant treatment | |
650 | 4 | |a Drug Resistance | |
650 | 4 | |a Drug resistance in cancer cells | |
650 | 4 | |a Neoplasms |x drug therapy | |
650 | 0 | 7 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 0 | 1 | |a Arzneimittelresistenz |0 (DE-588)4143180-7 |D s |
689 | 0 | |5 DE-188 | |
689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 1 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 1 | |5 DE-188 | |
700 | 1 | |a Houghton, Peter J. |e Verfasser |4 aut | |
700 | 1 | |a Houghton, Janet A. |e Verfasser |4 aut | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005749419&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-005749419 |
Datensatz im Suchindex
_version_ | 1804123055261220864 |
---|---|
adam_text | T 9 PRECLMCAL AND CLINICAL MODULATION OF ANTICANCER DRUGS KENNETH D. TEW
FOX CHASE CANCER CENTER PHILADELPHIA, PENNSYLVANIA PETER J. HOUGHTON ST.
JUDE CHILDREN S RESEARCH HOSPITAL MEMPHIS, TENNESSEE JANET A. HOUGHTON
ST. JUDE CHILDREN S RESEARCH HOSPITAL MEMPHIS, TENNESSEE CRC PRESS BOCA
RATON ANN ARBOR LONDON TOKYO CONTENTS SERIES PREFACE V PREFACE VI THE
AUTHORS VII 1. INTRODUCTION TO THE CONCEPT OF MODULATION 1 2. MODULATION
OF GLUTATHIONE 13 3. RADIOPROTECTORS AND RADIOSENSITIZERS AS MODULATING
AGENTS 79 4. MODULATION OF NITROSOUREAS * THE MER PHENOTYPE 103 5.
MODULATION OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE 125 6.
MODULATION OF 5-FLUOROURACIL 197 7. MISCELLANEOUS MODULATORS 323 INDEX
353 III
|
any_adam_object | 1 |
author | Tew, Kenneth D. Houghton, Peter J. Houghton, Janet A. |
author_facet | Tew, Kenneth D. Houghton, Peter J. Houghton, Janet A. |
author_role | aut aut aut |
author_sort | Tew, Kenneth D. |
author_variant | k d t kd kdt p j h pj pjh j a h ja jah |
building | Verbundindex |
bvnumber | BV008717954 |
callnumber-first | R - Medicine |
callnumber-label | RC271 |
callnumber-raw | RC271.A35 |
callnumber-search | RC271.A35 |
callnumber-sort | RC 3271 A35 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | XI 7000 |
ctrlnum | (OCoLC)27430107 (DE-599)BVBBV008717954 |
dewey-full | 616.99/4061 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99/4061 |
dewey-search | 616.99/4061 |
dewey-sort | 3616.99 44061 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02460nam a2200637 c 4500</leader><controlfield tag="001">BV008717954</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19940113 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">940105s1993 ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0849372917</subfield><subfield code="9">0-8493-7291-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)27430107</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008717954</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.A35</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tew, Kenneth D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Preclinical and clinical modulation of anticancer drugs</subfield><subfield code="c">Kenneth D. Tew ; Peter J. Houghton ; Janet A. Houghton</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton u.a.</subfield><subfield code="b">CRC Press</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 364 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Pharmacology and toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticancéreux</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antinéoplasiques - Pharmacologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antinéoplasiques - usage thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Traitement adjuvant</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cellules cancéreuses - Résistance aux médicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Résistance aux médicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Tumeurs - Traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Adjuvant treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug resistance in cancer cells</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-188</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Houghton, Peter J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Houghton, Janet A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005749419&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005749419</subfield></datafield></record></collection> |
id | DE-604.BV008717954 |
illustrated | Illustrated |
indexdate | 2024-07-09T17:23:41Z |
institution | BVB |
isbn | 0849372917 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005749419 |
oclc_num | 27430107 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-188 |
owner_facet | DE-355 DE-BY-UBR DE-188 |
physical | VII, 364 S. Ill., graph. Darst. |
publishDate | 1993 |
publishDateSearch | 1993 |
publishDateSort | 1993 |
publisher | CRC Press |
record_format | marc |
series2 | Pharmacology and toxicology |
spelling | Tew, Kenneth D. Verfasser aut Preclinical and clinical modulation of anticancer drugs Kenneth D. Tew ; Peter J. Houghton ; Janet A. Houghton Boca Raton u.a. CRC Press 1993 VII, 364 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmacology and toxicology Anticancéreux Antinéoplasiques - Pharmacologie Antinéoplasiques - usage thérapeutique Cancer - Traitement adjuvant Cellules cancéreuses - Résistance aux médicaments Chemotherapie gtt Geneesmiddelen gtt Kanker gtt Résistance aux médicaments Tumeurs - Traitement médicamenteux Antineoplastic Agents pharmacology Antineoplastic Agents therapeutic use Cancer Adjuvant treatment Drug Resistance Drug resistance in cancer cells Neoplasms drug therapy Arzneimittelresistenz (DE-588)4143180-7 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Cytostatikum (DE-588)4068347-3 s Arzneimittelresistenz (DE-588)4143180-7 s DE-188 Pharmakologie (DE-588)4045687-0 s Houghton, Peter J. Verfasser aut Houghton, Janet A. Verfasser aut GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005749419&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Tew, Kenneth D. Houghton, Peter J. Houghton, Janet A. Preclinical and clinical modulation of anticancer drugs Anticancéreux Antinéoplasiques - Pharmacologie Antinéoplasiques - usage thérapeutique Cancer - Traitement adjuvant Cellules cancéreuses - Résistance aux médicaments Chemotherapie gtt Geneesmiddelen gtt Kanker gtt Résistance aux médicaments Tumeurs - Traitement médicamenteux Antineoplastic Agents pharmacology Antineoplastic Agents therapeutic use Cancer Adjuvant treatment Drug Resistance Drug resistance in cancer cells Neoplasms drug therapy Arzneimittelresistenz (DE-588)4143180-7 gnd Cytostatikum (DE-588)4068347-3 gnd Pharmakologie (DE-588)4045687-0 gnd |
subject_GND | (DE-588)4143180-7 (DE-588)4068347-3 (DE-588)4045687-0 |
title | Preclinical and clinical modulation of anticancer drugs |
title_auth | Preclinical and clinical modulation of anticancer drugs |
title_exact_search | Preclinical and clinical modulation of anticancer drugs |
title_full | Preclinical and clinical modulation of anticancer drugs Kenneth D. Tew ; Peter J. Houghton ; Janet A. Houghton |
title_fullStr | Preclinical and clinical modulation of anticancer drugs Kenneth D. Tew ; Peter J. Houghton ; Janet A. Houghton |
title_full_unstemmed | Preclinical and clinical modulation of anticancer drugs Kenneth D. Tew ; Peter J. Houghton ; Janet A. Houghton |
title_short | Preclinical and clinical modulation of anticancer drugs |
title_sort | preclinical and clinical modulation of anticancer drugs |
topic | Anticancéreux Antinéoplasiques - Pharmacologie Antinéoplasiques - usage thérapeutique Cancer - Traitement adjuvant Cellules cancéreuses - Résistance aux médicaments Chemotherapie gtt Geneesmiddelen gtt Kanker gtt Résistance aux médicaments Tumeurs - Traitement médicamenteux Antineoplastic Agents pharmacology Antineoplastic Agents therapeutic use Cancer Adjuvant treatment Drug Resistance Drug resistance in cancer cells Neoplasms drug therapy Arzneimittelresistenz (DE-588)4143180-7 gnd Cytostatikum (DE-588)4068347-3 gnd Pharmakologie (DE-588)4045687-0 gnd |
topic_facet | Anticancéreux Antinéoplasiques - Pharmacologie Antinéoplasiques - usage thérapeutique Cancer - Traitement adjuvant Cellules cancéreuses - Résistance aux médicaments Chemotherapie Geneesmiddelen Kanker Résistance aux médicaments Tumeurs - Traitement médicamenteux Antineoplastic Agents pharmacology Antineoplastic Agents therapeutic use Cancer Adjuvant treatment Drug Resistance Drug resistance in cancer cells Neoplasms drug therapy Arzneimittelresistenz Cytostatikum Pharmakologie |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005749419&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT tewkennethd preclinicalandclinicalmodulationofanticancerdrugs AT houghtonpeterj preclinicalandclinicalmodulationofanticancerdrugs AT houghtonjaneta preclinicalandclinicalmodulationofanticancerdrugs |